Abstract
Background: Lichen sclerosus (LS) is a common and highly debilitating chronic inflammatory dermatosis that primarily affects genital skin in both sexes. Despite the utility of large genetic studies to reveal pathogenic mechanisms and suggest novel therapeutic targets, the genetic basis of LS remains largely unstudied. Objectives: To identify genomic loci at which common genetic variation influences LS susceptibility and establish associated pathogenic mechanisms. Methods: Sex-stratified genome-wide association studies of genital LS were performed in three European biobanks [UK Biobank, the Trøndelag Health Study (HUNT) and FinnGen]. Cases of LS were primarily identified via linked electronic health records from primary and/or secondary care. In total, 6681 female patients with LS and 407 255 female control individuals were included along with 970 male patients with LS and 331 484 male control individuals. Genome-wide association studies were combined through fixed-effect meta-analysis. Further analyses to identify putative causal variants and genes were performed, including statistical fine-mapping, functional annotation and assessment of colocalization with gene expression quantitative trait loci (eQTLs). Results: The major histocompatibility complex class II allele HLA-DRB1*12:01 was strongly associated with LS susceptibility in females [odds ratio (OR) 2.54, 95% confidence interval (CI) 2.28–2.83; P = 8.3 × 10–63] and in males (OR 2.30, 95% CI 1.73–3.07; P = 1.3 × 10–8). We found genome-wide significant associations (P < 5.0 × 10–8) at another 12 loci in females, including a potentially causal protein-altering variant in IGFLR1 [rs140952221; OR 0.71, 95% CI 0.67–0.74 (P = 2.1 × 10–11)]. Colocalization with established eQTLs in skin and immune tissues highlighted dysregulated expression of CD247, IL2RB and ALDH2 among potential LS pathomechanisms. Evidence was found for shared genetic effects between the sexes, albeit with diluted effect sizes in males (β = 0.42, 95% CI 0.21–0.64; P = 9.7 × 10–5). One further risk locus, at chromosome 5p13.2 was revealed by combined-sex meta-analysis. Conclusions: This study provides new insight into the pathogenesis of LS by identifying common genetic variation contributing to disease risk and implicating immune–inflammatory and metabolic pathways as potential future drug targets.
Funding Information
  • British Skin Foundation (MR/X030466/1)
  • Medical Research Council
  • Research Council of Finland (338229)
  • Fakultet for medisin og helsevitenskap, Norges Teknisk-Naturvitenskapelige Universitet
  • NTNU – Norwegian University of Science and Technology
  • the Liaison Committee for Education, Research and Innovation in Central Norway
  • the Joint Research Committee between St. Olavs Hospital
  • Faculty of Medicine and Health Sciences, NTNU – Norwegian University of Science and Technology
  • Liaison Committee for Education, Research and Innovation in Central Norway
  • National Institutes of Health
  • University of Michigan
  • Norges Forskningsråd
  • The Liaison Committee for Education
  • Research and Innovation in Central Norway
  • the Joint Research Committee between St. Olavs Hospital and the Faculty of Medicine and Health Sciences, NTNU – Norwegian University of Science and Technology

This publication has 27 references indexed in Scilit: